Compound information
- Natural Products
- ZC395229
- Molecular Formula
- C12H15NO4
- Molecular Weight
- 237.10010796 g/mol
- Structure
-
- IUPAC Name
- methyl (2R)-2-(benzyloxycarbonylamino)propanoate
- InChI
- InChI=1S/C12H15NO4/c1-9(11(14)16-2)13-12(15)17-8-10-6-4-3-5-7-10/h3-7,9H,8H2,1-2H3,(H,13,15)/t9-/m1/s1
- InChI Key
- OMDVFTVXPVXANK-SECBINFHSA-N
- SMILES
- COC(=O)[C@@H](C)NC(=O)OCc1ccccc1
- Source
- ZINC000002508269
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 17 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 64.63 Å2 | LogP | 1.77 |
LogS | -1.997 | LogD | 1.774 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.586 | Pgp substrate | 0.009 |
HIA | 0.964 | F20 % | 0.994 |
F30 % | 0.757 | Caco-2 | -4.745 |
MDCK | -4.663 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.914 | PPB | 63.97 |
VD | 0.459 | Fu | 0.565 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.917 | CYP1A2 substrate | 0.654 |
CYP2A6 substrate | 0.382 | CYP2B6 substrate | 0.525 |
CYP2C19 inhibitor | 0.905 | CYP2C19 substrate | 0.712 |
CYP2C8 substrate | 0.661 | CYP2C9 inhibitor | 0.125 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.006 |
CYP2D6 substrate | 0.337 | CYP2E1 substrate | 0.287 |
CYP3A4 inhibitor | 0.056 | CYP3A4 substrate | 0.77 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.827 | CL | 5.262 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.089 | Hepatotoxicity | 0.27 |
Mutagenicity | 0.195 | Rat Oral Acute Toxicity | 0.005 |
FDAMDD | 0.112 | Skin Sensitization | 0.003 |
Carcinogenicity | 0.003 | Eye Corrosion | 0.003 |
Eye Irritation | 0.067 | Respiratory Toxicity | 0.009 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.428 | IGC50 | 2.71 |
LC50FM | 3.576 | LC50DM | 5.225 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.119 | NR-AR-LBD | 0.224 |
NR-AhR | 0.002 | NR-Aromatase | 0.031 |
NR-ER | 0.205 | NR-ER-LBD | 0.318 |
NR-PPAR-gamma | 0.154 | SR-ARE | 0.039 |
SR-ATAD5 | 0.343 | SR-HSE | 0.076 |
SR-MMP | 0.004 | SR-p53 | 0.013 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.